ReviewRSC advances2024
Synthesis of nano-hydroxyapatite using emulsion, pyrolysis, combustion, and sonochemical methods and biogenic sources: a review.
Review in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Progress in Hydroxyapatite Nanocarriers for Targeted and Enhanced Osteoporosis Treatment: A Comprehensive Review.Molecular biotechnology · 2026Review
- Biomedical potential of bovine-derived hydroxyapatite: synthesis strategies, characterization and applications.RSC advances · 2026Review
- Synergistic antioxidant and anti-inflammatory scaffold based on ascorbic acid-enriched hydroxyapatite-PEG-ZnO composite from natural bone waste.Journal of materials science. Materials in medicine · 2026Article
- Calcifying nanoparticles induce apoptosis and calcification in bone marrow mesenchymal stem cellsWorld journal of stem cells · 2025Article
- Cuttlefish-Bone-Derived Hybrid Composite Scaffolds for Bone Tissue Engineering.Nanomaterials (Basel, Switzerland) · 2025Article
- Hybrid Hydroxyapatite-Metal Complex Materials Derived from Amino Acids and Nucleobases.Molecules (Basel, Switzerland) · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydroxyapatite (HAp) is comparable to materials in bone because its chemical components are similar to those contained in animal bone, and thus, its bioactive and biocompatible properties are similar. There are applications for HAp and relevant calcium phosphate in the medical and industrial sectors, and due to the rising demand for HAp nanoparticles, considerable work has been performed to develop a variety of synthetic pathways that incorporate scientifically and practically novel aspects. Numerous studies have been conducted to examine how changes in reaction parameters will successfully influence crucial HAp features. HAp can also be synthesized from biogenic sources such as HAp-rich fish scales or animal bones as an alternative to chemical precursors. Various preparation techniques produce crystals with varying sizes, but it has been found that nano-sized HAp exhibits a greater number of bioactive properties as compared to micron-sized HAp. Rather than considering conventional methods, this review focuses on alternative approaches such as emulsion, pyrolysis, combustion, and sonochemical methods along with waste bio-sources (biogenic sources) to obtain HAp. We summarize the currently accessible information pertaining to each synthesis process, while also focusing on their benefits and drawbacks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.